We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

9th October 2019
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App


Business digest


Pharma major AstraZeneca, headquartered in Cambridge, UK, has amended its collaboration agreement with US pharmaceutical company Ironwood Pharmaceuticals. AstraZeneca now has sole responsibility for the R&D, manufacture and commercialisation of the irritable bowel syndrome (IBS) treatment Linzess in mainland China, Hong Kong and Macau.

Read more

Filling the promethium gap

Maria Burke , 09/10/2019

One hundred and fifty years ago, the Russian chemist Dmitri Mendeleev proposed a ‘system of elements’ ordering the known chemical elements according to their atomic weights and chemical properties.

Read more